Tirzepatide 10mg · GIP/GLP-1 Dual Receptor Agonist (Mounjaro/Zepbound analog) · 99.3% Purity

What is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first 'twincretin' to reach clinical scale. By activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, tirzepatide delivers stronger satiety and glycemic effects than single-receptor agonists like Semaglutide, and remains the dominant tool in weight loss research.

What is Tirzepatide used for?

SURMOUNT trial data shows mean weight-loss of ~21% at 72 weeks at the 15 mg dose — substantially better than semaglutide head-to-head. Research applications include type-2 diabetes management, NAFLD biomarker reduction, energy expenditure work, and cardiovascular risk-factor research. Often stacked with Tesamorelin for visceral-fat-targeted protocols or with 5-Amino-1MQ for compound metabolic anti-aging work.

How does it work?

Dual GIP and GLP-1 receptor agonist; combined incretin action delivers greater weight-loss efficacy than GLP-1 alone. Read our complete research hub for the full literature review, or jump to our best peptides for weight loss article for comparator molecules.

Why this listing?

Tirzepatide is the same compound sold as Mounjaro (diabetes) and Zepbound (obesity). Following the 2025 GLP-1 capacity expansion, research-grade tirzepatide has dropped roughly 35% in price. Lumen Labs' batch TIR-2604-A tested 99.3% purity (HPLC), with full mass-spec identity confirmation.

How Peptide.best sources and verifies Tirzepatide

Every Tirzepatide listing on Peptide.best comes from a verified vendor that has passed our onboarding audit — GMP-licensed manufacturing facility, documented chain of custody, third-party Janoshik Analytical testing on every batch, and a published Certificate of Analysis. Lumen Labs (the seller on this listing) currently maintains a 4.9-star average across all their products. Compare the five live offers on the right side of this page — Peptide.best forces vendors to compete on price and purity for the same SKU, so you always see the best current deal at the top, with the COA-verified purity, shipping speed, and seller rating side-by-side. Looking for alternatives in the same weight loss space? Semaglutide and the other peptides listed under our Weight Loss category are the most commonly compared alternatives.

Commonly stacked with

Semaglutide · Retatrutide · AOD-9604 · 5-Amino-1MQ. See the peptide stacks page for full protocol writeups.

Compliance notice

Tirzepatide has not been evaluated by the FDA for any indication. All statements on this page are based on published research and are not medical claims. Some products may be sold for research purposes only as marked. Consult a licensed healthcare provider before use. See our full disclaimer.

Research literature

Tirzepatide has been the subject of growing peer-reviewed and preclinical research across the weight loss domain. The current PubMed index returns several hundred citations spanning mechanism, dose-response, and adverse-event reporting.

Key references commonly cited in Tirzepatide research:

• Mechanism papers covering dual gip and glp-1 receptor agonist; combined incretin action delivers greater weight-loss efficacy than glp-1 alone.
• Dose-response work in rodent models (most studied species)
• Comparator-molecule trials vs. Semaglutide and other peptides in the same class
• Safety / pharmacovigilance datasets where available

For a full reference list, see the Peptide.best Research Hub or the dedicated Weight Loss pillar article.

Standard research dosing

Research protocols typically start at 2.5 mg/week with 4-week dose-up steps to 5, 7.5, 10, 12.5, and 15 mg/week. Subcutaneous, weekly.

Reconstitution

This product ships as lyophilized powder. Reconstitute with Bacteriostatic water (2mL) for stable refrigerated storage. Once reconstituted, use within 30 days; keep at 2–8°C.

Protocol notes

For full protocols and stacking guidance, see our peptide dosing guides. Always start at the low end of the published range and titrate based on individual response. Half-life (~5 days (weekly dosing)) determines dosing frequency.

Reported side effects

Most common: nausea, diarrhea, decreased appetite. Less common: injection-site reaction, fatigue. Same thyroid C-cell warnings as semaglutide. Not for combination with sulfonylureas without medical supervision.

Contraindications

Do not use during pregnancy or lactation. Do not combine with other peptides without reviewing pharmacology. Consult a licensed healthcare provider before beginning any peptide research protocol. Discontinue immediately if any adverse reaction occurs and contact your provider.

Drug interactions

Limited interaction data exists for most research peptides. Be especially cautious when combining with prescription medications affecting the same physiological pathway as Tirzepatide (weight loss pathway).

Certificate of Analysis

Every batch of Tirzepatide sold on Peptide.best ships with a third-party Certificate of Analysis (COA) from Janoshik Analytical — the most-cited independent peptide testing lab in the research community.

Current batch testing summary

• Batch ID: TIR-2604-A
• Test date: 04/14/2026
• Peptide content (HPLC): 99.3%
• Mass-spec identity: Confirmed (target mass match)
• Endotoxin (LAL): Below detection limit
• Residual solvents: Within USP <467> limits

Download full COA PDF

For our overall testing process and chain-of-custody details, see Trust & Safety.

Q: Is Tirzepatide legal to purchase?

A: Tirzepatide is sold on Peptide.best for research purposes where applicable. Legal status varies by jurisdiction. See our disclaimer for full details.

Q: How long until I see effects?

A: Timing depends on protocol, dose, and individual response. Most users report observable changes within 2–6 weeks of consistent dosing per the standard research protocols. See the Dosing & Protocol tab.

Q: Can I stack Tirzepatide with other peptides?

A: Yes — see commonly stacked peptides in the Overview tab, or browse our peptide stacks page for full protocol writeups.

Q: Why is the price lower than pharmacy retail or other research sites?

A: Peptide.best aggregates verified vendors and forces them to compete in a single checkout. Vendors save on customer-acquisition cost; the savings pass to you. Every batch is still 3rd-party COA tested.

About Lumen Labs

Lumen Labs is one of the six verified vendor partners on Peptide.best. They maintain a 4.9-star average rating across all products and submit every batch to third-party HPLC analysis before it ships.

All Lumen Labs products on Peptide.best ship from a GMP-licensed contract manufacturing facility and are tested by Janoshik Analytical. Cold-chain shipping is included on temperature-sensitive products.